Literature DB >> 19918155

Methodological issues in trials of complementary and alternative medicine interventions.

Alla Sikorskii1, Gwen Wyatt, David Victorson, Gwen Faulkner, Mohammad Hossein Rahbar.   

Abstract

BACKGROUND: Complementary and alternative medicine (CAM) use is widespread among cancer patients. Information on safety and efficacy of CAM therapies is needed for both patients and healthcare providers. Well-designed randomized clinical trials of CAM therapy interventions can inform both clinical research and practice.
OBJECTIVES: The aim of this study was to review important issues that affect the design of randomized clinical trials for CAM interventions.
METHODS: Using the methods component of the Consolidated Standards for Reporting Trials as a guiding framework and a National Cancer Institute-funded reflexology study as an exemplar, methodological issues related to participants, intervention, objectives, outcomes, sample size, randomization, blinding, and statistical methods were reviewed. DISCUSSION: Trials of CAM interventions designed and implemented according to appropriate methodological standards will facilitate the needed scientific rigor in CAM research. Interventions in CAM can be tested using proposed methodology, and the results of testing will inform nursing practice in providing safe and effective supportive care and in improving the well-being of patients.

Entities:  

Mesh:

Year:  2009        PMID: 19918155      PMCID: PMC2880328          DOI: 10.1097/NNR.0b013e3181bf15fe

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  38 in total

1.  The escalating cost and prevalence of alternative medicine.

Authors:  Alastair H MacLennan; David H Wilson; Anne W Taylor
Journal:  Prev Med       Date:  2002-08       Impact factor: 4.018

2.  High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care.

Authors:  Barrie R Cassileth; Andrew J Vickers
Journal:  J Clin Oncol       Date:  2005-02-22       Impact factor: 44.544

3.  Access to conventional medical care and the use of complementary and alternative medicine.

Authors:  José A Pagán; Mark V Pauly
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Feb       Impact factor: 6.301

4.  Why patients use alternative medicine: results of a national study.

Authors:  J A Astin
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

5.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

6.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

Review 7.  Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.

Authors:  Cornelis J A Punt; Marc Buyse; Claus-Henning Köhne; Peter Hohenberger; Roberto Labianca; Hans J Schmoll; Lars Påhlman; Alberto Sobrero; Jean-Yves Douillard
Journal:  J Natl Cancer Inst       Date:  2007-06-27       Impact factor: 13.506

8.  Disclosure of complementary and alternative medicine to conventional medical providers: variation by race/ethnicity and type of CAM.

Authors:  Maria T Chao; Christine Wade; Fredi Kronenberg
Journal:  J Natl Med Assoc       Date:  2008-11       Impact factor: 1.798

9.  Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.

Authors:  Suzanna M Zick; Mack T Ruffin; Julia Lee; Daniel P Normolle; Rivka Siden; Sara Alrawi; Dean E Brenner
Journal:  Support Care Cancer       Date:  2008-11-13       Impact factor: 3.603

10.  Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005.

Authors:  Heather S Boon; Folashade Olatunde; Suzanna M Zick
Journal:  BMC Womens Health       Date:  2007-03-30       Impact factor: 2.809

View more
  6 in total

1.  Coordination and management of multisite complementary and alternative medicine (CAM) therapies: experience from a multisite reflexology intervention trial.

Authors:  Mohammad H Rahbar; Gwen Wyatt; Alla Sikorskii; David Victorson; Manouchehr Ardjomand-Hessabi
Journal:  Contemp Clin Trials       Date:  2011-06-02       Impact factor: 2.226

2.  Concordance between patient reports of cancer-related symptoms and medical records documentation.

Authors:  Alla Sikorskii; Gwen Wyatt; Deimante Tamkus; David Victorson; Mohammad Hossein Rahbar; Suzie Ahn
Journal:  J Pain Symptom Manage       Date:  2012-06-13       Impact factor: 3.612

3.  Chiropractor interaction and treatment equivalence in a pilot randomized controlled trial: an observational analysis of clinical encounter video-recordings.

Authors:  Stacie A Salsbury; James W DeVocht; Maria A Hondras; Michael B Seidman; Clark M Stanford; Christine M Goertz
Journal:  Chiropr Man Therap       Date:  2014-12-03

4.  A Randomized Controlled Trial for the Effectiveness of Progressive Muscle Relaxation and Guided Imagery as Anxiety Reducing Interventions in Breast and Prostate Cancer Patients Undergoing Chemotherapy.

Authors:  Andreas Charalambous; Margarita Giannakopoulou; Evangelos Bozas; Lefkios Paikousis
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-06       Impact factor: 2.629

5.  Themes Underlying Australian General Practitioner Views towards Chiropractic and Osteopathy: An Assessment of Free Text Data from a Cross-Sectional Survey.

Authors:  Sandra Grace; Roger Engel; Ian Jalsion
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-14       Impact factor: 2.629

6.  A systematic review of complementary and alternative medicine in oncology: Psychological and physical effects of manipulative and body-based practices.

Authors:  Nicolas Calcagni; Kamel Gana; Bruno Quintard
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.